Bridgeway Capital Management’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-3,200
Closed -$278K – 1434
2022
Q3
$278K Hold
3,200
– – 0.01% 1066
2022
Q2
$364K Hold
3,200
– – 0.01% 949
2022
Q1
$414K Hold
3,200
– – 0.01% 987
2021
Q4
$577K Hold
3,200
– – 0.01% 941
2021
Q3
$475K Sell
3,200
-300
-9% -$46K 0.01% 1048
2021
Q2
$530K Buy
+3,500
New +$487K 0.01% 1050
2020
Q3
– Sell
-4,100
Closed -$290K – 1350
2020
Q2
$290K Hold
4,100
– – 0.01% 1051
2020
Q1
$269K Sell
4,100
-2,400
-37% -$191K 0.01% 961
2019
Q4
$531K Sell
6,500
-700
-10% -$53.7K 0.01% 958
2019
Q3
$520K Buy
+7,200
New +$528K 0.01% 944

Other funds holding OMCL

Bridgeway Capital Management's OMCL Position: Q4 2022 in Review

Bridgeway Capital Management sold out of Omnicell (OMCL) in Q4 2022, closing a stake of 3,200 shares — an estimated $278K sold.

Bridgeway Capital Management first reported a position in OMCL in Q3 2019 and held it in 10 quarters. The position peaked at $577K in Q4 2021. 328 funds tracked by Wall St. Rank hold OMCL as of Q4 2022.

  • Bridgeway Capital Management reported no remaining Omnicell position as of Q4 2022 after selling out during the quarter.
  • Bridgeway Capital Management sold 3,200 Omnicell shares in Q4 2022, an estimated $278K.
  • Bridgeway Capital Management first reported a position in Omnicell in Q3 2019 and held it in 10 quarters.
  • Bridgeway Capital Management's Omnicell position peaked at $577K in Q4 2021.
  • 328 funds tracked by Wall St. Rank held Omnicell as of Q4 2022.

Based on Bridgeway Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.